Three-Drug immune attack on deadly pancreatic cancer
Disease control
Terminated
This study is testing whether a combination of three immunotherapy drugs can help control metastatic pancreatic cancer after initial chemotherapy. The trial compares two different treatment approaches to see which works better at keeping the cancer from growing. About 46 people w…
Phase: PHASE1, PHASE2 • Sponsor: James Cleary, MD, PhD • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC